Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
The Lancet ( IF 168.9 ) Pub Date : 2017-10-01 , DOI: 10.1016/s1470-2045(17)30622-8 Beatrice Seddon , Sandra J Strauss , Jeremy Whelan , Michael Leahy , Penella J Woll , Fiona Cowie , Christian Rothermundt , Zoe Wood , Charlotte Benson , Nasim Ali , Maria Marples , Gareth J Veal , David Jamieson , Katja Küver , Roberto Tirabosco , Sharon Forsyth , Stephen Nash , Hakim-Moulay Dehbi , Sandy Beare
The Lancet ( IF 168.9 ) Pub Date : 2017-10-01 , DOI: 10.1016/s1470-2045(17)30622-8 Beatrice Seddon , Sandra J Strauss , Jeremy Whelan , Michael Leahy , Penella J Woll , Fiona Cowie , Christian Rothermundt , Zoe Wood , Charlotte Benson , Nasim Ali , Maria Marples , Gareth J Veal , David Jamieson , Katja Küver , Roberto Tirabosco , Sharon Forsyth , Stephen Nash , Hakim-Moulay Dehbi , Sandy Beare
|
For many years, first-line treatment for locally advanced or metastatic soft-tissue sarcoma has been doxorubicin. This study compared gemcitabine and docetaxel versus doxorubicin as first-line treatment for advanced or metastatic soft-tissue sarcoma.
中文翻译：
吉西他滨和多西他赛与阿霉素相比是先前未经治疗的晚期不可切除或转移性软组织肉瘤（GeDDiS）的一线治疗：一项随机对照的3期临床试验。
多年来，阿霉素一直是局部晚期或转移性软组织肉瘤的一线治疗。这项研究比较了吉西他滨和多西他赛与阿霉素作为晚期或转移性软组织肉瘤的一线治疗方法。
更新日期：2017-09-05
中文翻译：
吉西他滨和多西他赛与阿霉素相比是先前未经治疗的晚期不可切除或转移性软组织肉瘤（GeDDiS）的一线治疗：一项随机对照的3期临床试验。
多年来，阿霉素一直是局部晚期或转移性软组织肉瘤的一线治疗。这项研究比较了吉西他滨和多西他赛与阿霉素作为晚期或转移性软组织肉瘤的一线治疗方法。
京公网安备 11010802027423号